A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation

BACKGROUND: Currently, there are no effective medications to reverse periodontal disease (PD)-induced bone loss. The objective of this study was to test a new anabolic compound, LLP2A-Ale, or with the combination treatment of mesenchymal stromal cell (MSC), in the treatment of bone loss secondary to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Min, Liu, Lixian, Liu, Ruiwu, Lam, Kit S., Lane, Nancy E., Yao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664094/
https://www.ncbi.nlm.nih.gov/pubmed/33187558
http://dx.doi.org/10.1186/s40360-020-00454-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664094/
https://www.ncbi.nlm.nih.gov/pubmed/33187558
http://dx.doi.org/10.1186/s40360-020-00454-x

Ejemplares similares